Expertise in
4
conditions

Matthew E. Burge

Brisbane, QLD, AU 
Expertise in
4
conditions
Brisbane, QLD, AU 

Overview

Matthew Burge practices practicing medicine in Brisbane, Australia.

Mr. Burge is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, and Pancreaticoduodenectomy.

He is actively involved in clinical research, co-authoring 91 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Brisbane, QLD, Australia
Other Locations
Herston, QLD, Australia
Chermside, QLD 4032, Australia
St. Vincent's Hospital, Hobart, TAS And South West Healthcare, Warrnambool, VIC, Australia
QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomised Phase III Open Label Study of Regorafenib + Nivolumab vs Standard Chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)
A Randomised Phase III Open Label Study of Regorafenib + Nivolumab vs Standard Chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)
Enrollment Status: Completed
Publish Date: June 10, 2026
Intervention Type: Drug, Biological
Study Drugs: Regorafenib, Nivolumab, Docetaxel, Paclitaxel, Irinotecan, Trifluridine/Tipracil
Study Phase: Phase 3
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer
Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer
Enrollment Status: Completed
Publish Date: August 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

91 Total Publications

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2026

Frequently Asked Questions about Matthew E. Burge

Is Matthew E. Burge a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Matthew E. Burge is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Matthew E. Burge participate in research or clinical trials?

Yes. Matthew E. Burge has published 91 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Matthew E. Burge's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Burge's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile